• Conference Recording
  • On-Demand
  • Nutrition Therapy
 CME/CE Expiration Date: 11/1/25*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.  
  • 0.25 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Physical Activity
 CME/CE Expiration Date: 11/1/25*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.  
  • 0.25 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
The BIG Picture — NAFLD, the Sentinel Disorder of Metabolic SyndromeCME/CE Expiration Date: 11/1/25
  • 1.00 AMA PRA Category 1 Credit
  • On-Demand
  • Behavioral Modification
CME/CE Expiration Date: 10/16/25*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.  
  • 1.00 AMA PRA Category 1 Credit
  • On-Demand
  • Nutrition Therapy
Many practices do not have nutritional professionals to assist their patients make eating plan selections. Providers are called upon to help the patients with this important pillar of care.
  • 1.00 AMA PRA Category 1 Credit
  • On-Demand
Sleep and Obesity: Why You Should be Cognizant of the Two CME/CE Expiration Date: 3/19/25
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Special Populations
  • Surgery
  • Practice Management
  • Adiposity Related Diseases
  • Physical Activity
  • Pharmacotherapy
  • Patient Assessment
Obesity Medicine 2023 - Spring Obesity Summit 
  • 22.50 AMA PRA Category 1 Credit
  • On-Demand
  • ABOM Exam Preparation
Review Course for the ABOM Exam - 2023
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Sarcopenic obesity presents numerous risks to health and quality of life.
  • 1.00 AMA PRA Category 1 Credit

Pages